Medical News

RSS

USPTO awards Medicis new patent for SOLODYN Extended Release Tablets

Medicis today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,790,705 related to the use of SOLODYN® (minocycline HCI, USP) Extended Release Tablets. The new patent, entitled "Minocycline Oral Dosage Forms for the Treatment of Acne," relates to the use of dosage forms of SOLODYN which provide approximately 1 mg/kg dosing based on the body weight of the person, and expires in 2027.

8 Sep 2010

Columbus Regional Hospital joins Indiana Network for Patient Care

Columbus Regional Hospital is bringing the nation's largest health information exchange to the Columbus, Ind. area to better serve patients. Joining over 65 hospitals, long term care facilities and other healthcare providers, Columbus Regional Hospital is now part of a statewide network that allows physicians to securely access necessary information to make decisions critical to patient care.

8 Sep 2010

McLeod Health implements Merge Healthcare's radiology, cardiology workflow solutions

Merge Healthcare, a leading health IT solutions provider, today announced a new contract with McLeod Health (Florence, SC). This agreement integrates the Merge cardiology workflow solutions with McLeod's existing Merge radiology solution, allowing McLeod to streamline workflow and improve quality data across their entire cardiovascular service line, while also providing a unified image management platform.

8 Sep 2010

Vela Laboratories renews GMP certificate for analytical and Quality Control laboratories

Vela Laboratories, a provider of analytical services to the global biopharmaceutical industry, today announced the renewal of the GMP certificate for its analytical and Quality Control laboratories until 2013.

8 Sep 2010

Liberator Medical Holdings' subsidiary receives 2010 Governor's Business Diversification Award

Liberator Medical Holdings, Inc. today announced its wholly owned subsidiary, Liberator Medical Supply, has received the 2010 Governor's Business Diversification Award in the Business Expansion category.

8 Sep 2010

Tampa, Florida-based medical institution purchases Streamline Health's document workflow solutions

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that a leading Tampa, Florida-based medical institution has purchased three additional workflow licenses to expand the use of Streamline Health's document workflow solutions to help optimize business processes across the enterprise and improve operational efficiencies. Streamline Health expects at least two of the workflow solutions to be fully implemented and operational prior to the conclusion of the current fiscal year.

8 Sep 2010

Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients

Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.

8 Sep 2010

Positive results from YM BioSciences' CYT997 Phase I study for vascular disruption in tumors

YM BioSciences Inc., today announced the publication of Phase I results demonstrating that CYT997, a novel vascular disrupting agent (VDA), was well tolerated at doses that were associated with pharmacodynamic evidence of vascular disruption in tumors. The article entitled "Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent," was published in the premier cancer journal, the British Journal of Cancer.

8 Sep 2010

Champions Biotechnology signs agreement to test Cephalon's CEP-32496 in Biomerk Tumorgraft platform

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.

8 Sep 2010

Emergent BioSolutions initiates Phase I clinical trial for anthrax monoclonal antibody therapeutic

Emergent BioSolutions Inc. announced today that the Phase I clinical trial for its anthrax monoclonal antibody therapeutic has commenced with the dosing of the first subject. Emergent's fully human monoclonal antibody product candidate is being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

8 Sep 2010

Perrigo receives FDA approval to manufacture, market Imiquimod Cream, 5%

Perrigo Company announced it received FDA approval from the U.S. Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. Perrigo will vertically integrate this product with their own API.

8 Sep 2010

First Edition: September 8, 2010

In today's headlines, reports about how health reform is playing on the campaign trail and the latest on health insurance premium hikes.

8 Sep 2010

Preventive health services can save lives at little or no cost

Preventive health services such as daily aspirin use, tobacco cessation screening and alcohol abuse screening can potentially save 2 million lives and nearly $4 billion annually, according to a new paper produced by the National Commission on Prevention Priorities (NCPP). The NCPP is convened by the Partnership for Prevention. Four of the five lead authors perform research with HealthPartners Research Foundation.

8 Sep 2010

AVAC welcomes new Global HIV Vaccine Enterprise Scientific Strategic Plan

AVAC welcomes the new Global HIV Vaccine Enterprise Scientific Strategic Plan, released today, as a critical document that the field must implement as part of ongoing efforts to improve coordination, efficiency and transparency to quickly capitalize on recent advances in AIDS vaccine research.

8 Sep 2010

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Clinical trials in a variety of areas within interventional cardiovascular medicine that will be presented at TCT 2010 will directly affect the way that people with cardiovascular disease are treated. Breakthroughs in science and medical research, presented exclusively at TCT, will lead to new treatments that are minimally invasive and involve shorter recovery times. Among the topics being covered are stenting in the femoral artery, polymer-free drug-eluting stents, valves and drug-eluting balloons used in angioplasty.

8 Sep 2010

Save the Children report finds neediest children in many developing countries are overlooked

The deaths of four million of the world's poorest children over 10 years could have been avoided if governments had not turned "a blind eye" to the neediest children, said a report from Save the Children, released on Tuesday, the U.K. Press Association reports (9/6).

8 Sep 2010

Patient panels associated with lower physician quality rankings: Study

Patients panels (used to rate the quality of care of physicians) with greater proportions of underinsured, minority and non-English speaking patients were associated with lower physician quality rankings, according to a study in the September 8 issue of JAMA.

8 Sep 2010

Trius Therapeutics announces presentations from drug development programs at 50th ICAAC

Trius Therapeutics, Inc. announced today that the results of multiple studies from its drug development programs, including its lead antibiotic drug candidate torezolid phosphate (TR-701), will be presented in poster presentations at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting in Boston September 12-15.

8 Sep 2010

Mary Ann Liebert launches Childhood Obesity journal to promote clinical advances

Publisher Mary Ann Liebert announced the launch of Childhood Obesity to provide physicians, nurses, dietitians, diabetes educators, nutritionists, psychologists, educators and school nurses, community organizers, and policymakers with effective prevention and treatment strategies that promote environmental and policy changes, patient education and motivation tools, and clinical advances in the field.

8 Sep 2010

'Revenge of the Introverts' addresses new research

The work of West Virginia author and psychologist Laurie Helgoe of Charleston is the cover story in the latest issue of the national magazine, Psychology Today.

8 Sep 2010

Medical News

USPTO awards Medicis new patent for SOLODYN Extended Release Tablets

Columbus Regional Hospital joins Indiana Network for Patient Care

McLeod Health implements Merge Healthcare's radiology, cardiology workflow solutions

Vela Laboratories renews GMP certificate for analytical and Quality Control laboratories

Liberator Medical Holdings' subsidiary receives 2010 Governor's Business Diversification Award

Tampa, Florida-based medical institution purchases Streamline Health's document workflow solutions

Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients

Positive results from YM BioSciences' CYT997 Phase I study for vascular disruption in tumors

Champions Biotechnology signs agreement to test Cephalon's CEP-32496 in Biomerk Tumorgraft platform

Emergent BioSolutions initiates Phase I clinical trial for anthrax monoclonal antibody therapeutic

Perrigo receives FDA approval to manufacture, market Imiquimod Cream, 5%

First Edition: September 8, 2010

Preventive health services can save lives at little or no cost

AVAC welcomes new Global HIV Vaccine Enterprise Scientific Strategic Plan

Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010

Save the Children report finds neediest children in many developing countries are overlooked

Patient panels associated with lower physician quality rankings: Study

Trius Therapeutics announces presentations from drug development programs at 50th ICAAC

Mary Ann Liebert launches Childhood Obesity journal to promote clinical advances

'Revenge of the Introverts' addresses new research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News